From the College of Medicine (Almuqbil, Aldoohan, Alhinti, Alkhodair, Kashgari, Altwaijri, Alrumayyan), King Saud bin Abdulaziz University for Health Sciences, from King Abdullah International Medical Research Center (Almuqbil, Alkhodair), Ministry of National Guard, from the Division of Pediatric Neurology (Almuqbil Altwaijri, Alrumayyan), Department of Pediatrics, King Abdullah Specialized Children's Hospital, National Guard Health Affairs, from the Department of Family Medicine and Primary Health Care (Abdulmajeed), King Abdulaziz Medical City, from the Division of Pediatric Dermatology (Alkhodair), Department of Pediatrics, King Abdullah Specialized Children's Hospital (KASCH), National Guard Health Affairs, and from Department of Pediatric (Baarmah), King Abdullah Bin Abdulaziz University Hospital, Princess Nourah bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia.
Neurosciences (Riyadh). 2024 May;29(2):113-121. doi: 10.17712/nsj.2024.2.20230061.
To determine the prevalence of tuberous sclerosis complex (TSC) in the paediatric Saudi population and to characterise the range of clinical symptoms, neurocutaneous findings, neuroimaging results, and complications of the disease.
A total of 61 genetically confirmed TSC patients from the National Guard Health Affairs (NGHA) in Saudi Arabia were the subject of this retrospective descriptive analysis. The data were presented using descriptive measures.
The mean age at diagnosis was found to be 4.9 years. Subependymal nodules (86.9%), numerous cortical tubers and/or radial migration lines (63.9%), and hypomelanotic macules (63.9%) were the 3 most common significant criteria. The vast majority (86.9%) of those diagnosed had epilepsy, of which 50% were considered medically intractable. Nearly half of our subjects underwent genetic testing, which revealed that TSC2 predominated over TSC1. Symptoms of Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND) were present in 66.7% of TSC1 patients and 73.9% of TSC2 patients.
The findings of this study demonstrate that the clinical spectrum of TSC among Saudi children is consistent with the body of existing literature. The TSC2 was more prevalent than TSC1. The most frequent signs were cutaneous and neurological. Monitoring TSC patients regularly is crucial to identify any issues as soon as possible.
确定沙特儿科人群中结节性硬化症(TSC)的患病率,并描述其临床表现、神经皮肤学发现、神经影像学结果和疾病并发症的范围。
本回顾性描述性分析的对象是来自沙特阿拉伯国民卫队卫生事务部(NGHA)的 61 名经基因确认的 TSC 患者。数据采用描述性措施呈现。
诊断时的平均年龄为 4.9 岁。最常见的显著标准是室管膜下结节(86.9%)、大量皮质结节和/或放射状移行线(63.9%)和色素减退斑(63.9%)。被诊断出的患者中绝大多数(86.9%)患有癫痫,其中 50%被认为是药物难治性癫痫。我们的研究对象中有近一半进行了基因检测,结果显示 TSC2 比 TSC1 更为常见。66.7%的 TSC1 患者和 73.9%的 TSC2 患者存在结节性硬化症相关神经精神障碍(TAND)症状。
本研究结果表明,沙特儿童的 TSC 临床表现与现有文献一致。TSC2 比 TSC1 更为常见。最常见的症状是皮肤和神经方面的。定期监测 TSC 患者至关重要,以便尽早发现任何问题。